You are here

Henry Solomon, MD, FACC
Cardiovascular Business
The debate whether industry support of academic activity is appropriate and can be managed effectively has increased over the last several years. While most agree that industry support has been vital to the development of new therapies to treat diseases, there also have been reports of egregious conflicts of interest from all sidesindustry and academia.